Literature DB >> 23820859

Paediatric rheumatology: Juvenile idiopathic arthritis--are biologic agents effective for pain?

Alessandro Consolaro, Angelo Ravelli.   

Abstract

Biologic medications are highly efficacious in juvenile idiopathic arthritis. However, a recent study found that a subgroup of children treated with anti-TNF agents had persistent pain despite good disease control. This finding highlights the importance of monitoring pain symptoms during treatment with modern DMARDs.

Entities:  

Year:  2013        PMID： 23820859     DOI： 10.1038/nrrheum.2013.108

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

Review 1.  Developing outcome measures for paediatric rheumatic diseases.

Authors:  Hermine I Brunner; Angelo Ravelli
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

2.  Painless juvenile rheumatoid arthritis.

Authors:  D D Sherry; J Bohnsack; K Salmonson; C A Wallace; E Mellins
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

3.  Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis.

Authors:  Nicolino Ruperto; Daniel J Lovell; Tracy Li; Flavio Sztajnbok; Claudia Goldenstein-Schainberg; Morton Scheinberg; Inmaculada Calvo Penades; Michael Fischbach; Javier Orozco Alcala; Philip J Hashkes; Christine Hom; Lawrence Jung; Loredana Lepore; Sheila Oliveira; Carol Wallace; Maria Alessio; Pierre Quartier; Elisabetta Cortis; Anne Eberhard; Gabriele Simonini; Irene Lemelle; Elizabeth Candell Chalom; Leonard H Sigal; Alan Block; Allison Covucci; Marleen Nys; Alberto Martini; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07-01       Impact factor: 4.794

Review 4.  Pediatric pain syndromes and management of pain in children and adolescents with rheumatic disease.

Authors:  Kelly K Anthony; Laura E Schanberg
Journal:  Pediatr Clin North Am       Date:  2005-04       Impact factor: 3.278

Review 5.  Emerging drugs to treat juvenile idiopathic arthritis.

Authors:  Nicolino Ruperto; Alberto Martini
Journal:  Expert Opin Emerg Drugs       Date:  2011-04-30       Impact factor: 4.191

6.  Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis.

Authors:  Pablo Garcia-Munitis; Marcia Bandeira; Angela Pistorio; Silvia Magni-Manzoni; Nicolino Ruperto; Ambra Schivo; Alberto Martini; Angelo Ravelli
Journal:  Arthritis Rheum       Date:  2006-04-15

7.  Daily pain and symptoms in children with polyarticular arthritis.

Authors:  Laura E Schanberg; Kelly K Anthony; Karen M Gil; Elana C Maurin
Journal:  Arthritis Rheum       Date:  2003-05

Review 8.  Treatment of chronic pain in pediatric rheumatic disease.

Authors:  Yukiko Kimura; Gary A Walco
Journal:  Nat Clin Pract Rheumatol       Date:  2007-04

9.  Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.

Authors:  F H M Prince; L M Geerdink; G J J M Borsboom; M Twilt; M A J van Rossum; E P A H Hoppenreijs; R Ten Cate; Y Koopman-Keemink; M van Santen-Hoeufft; H Raat; L W A van Suijlekom-Smit
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

10.  Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment.

Authors:  Johanne Jeppesen Lomholt; Mikael Thastum; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2013-05-06       Impact factor: 3.054
  10 in total
  9 in total

Review 1.  Management of juvenile idiopathic arthritis: hitting the target.

Authors:  Claas Hinze; Faekah Gohar; Dirk Foell
Journal:  Nat Rev Rheumatol       Date:  2015-01-06       Impact factor: 20.543

Review 2.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer E Weiss; Nadia J C Luca; Alexis Boneparth; Jennifer Stinson
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

Review 3.  Neural mechanisms underlying the pain of juvenile idiopathic arthritis.

Authors:  Luke La Hausse de Lalouvière; Yiannis Ioannou; Maria Fitzgerald
Journal:  Nat Rev Rheumatol       Date:  2014-02-04       Impact factor: 20.543

4.  Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.

Authors:  Sara Verazza; Sergio Davì; Alessandro Consolaro; Francesca Bovis; Antonella Insalaco; Silvia Magni-Manzoni; Rebecca Nicolai; Denise Pires Marafon; Fabrizio De Benedetti; Valeria Gerloni; Irene Pontikaki; Francesca Rovelli; Rolando Cimaz; Achille Marino; Francesco Zulian; Giorgia Martini; Serena Pastore; Chiara Sandrin; Fabrizia Corona; Marta Torcoletti; Giovanni Conti; Claudia Fede; Patrizia Barone; Marco Cattalini; Elisabetta Cortis; Luciana Breda; Alma Nunzia Olivieri; Adele Civino; Rosanna Podda; Donato Rigante; Francesco La Torre; Gianfranco D'Angelo; Mauro Jorini; Romina Gallizzi; Maria Cristina Maggio; Rita Consolini; Alessandro De Fanti; Valentina Muratore; Maria Giannina Alpigiani; Nicolino Ruperto; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-12-20       Impact factor: 3.054

5.  Patterns of pain over time among children with juvenile idiopathic arthritis.

Authors:  Amir Rashid; Lis Cordingley; Roberto Carrasco; Helen E Foster; Eileen M Baildam; Alice Chieng; Joyce E Davidson; Lucy R Wedderburn; Yiannis Ioannou; Flora McErlane; Suzanne M M Verstappen; Kimme L Hyrich; Wendy Thomson
Journal:  Arch Dis Child       Date:  2017-11-25       Impact factor: 3.791

6.  Altered sensory innervation and pain hypersensitivity in a model of young painful arthritic joints: short- and long-term effects.

Authors:  Luke La Hausse De Lalouviere; Oscar Morice; Maria Fitzgerald
Journal:  Inflamm Res       Date:  2021-03-13       Impact factor: 4.575

7.  Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alessandro Consolaro; Alessandra Alongi; Gabriella Giancane; Roberta Naddei; Valentina Natoli; Francesca Ridella; Marco Burrone; Silvia Rosina; Gaelle Chedeville; Ekaterina Alexeeva; Gerd Horneff; Ivan Foeldvari; Giovanni Filocamo; Tamàs Constantin; Nicolino Ruperto
Journal:  RMD Open       Date:  2022-03

8.  Evidence of persistent glial cell dysfunction in the anterior cingulate cortex of juvenile idiopathic arthritis children: a proton MRS study.

Authors:  Haiwei Han; Ji Hong Xiao; Yifei Weng; Hongyan Liang; Chengkun Han; Cuili Yi; Kezhao Lin; Hua Wu
Journal:  Pediatr Rheumatol Online J       Date:  2022-07-27       Impact factor: 3.413

9.  Spinal interleukin-6 contributes to central sensitisation and persistent pain hypersensitivity in a model of juvenile idiopathic arthritis.

Authors:  Charlie H T Kwok; Annastazia E Learoyd; Julia Canet-Pons; Tuan Trang; Maria Fitzgerald
Journal:  Brain Behav Immun       Date:  2020-08-10       Impact factor: 7.217
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.